GOOS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Canada Goose is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near $11.43 pre-market with weak technical momentum, negative analyst sentiment, hedge fund selling, and no strong proprietary buy signal. For an impatient investor who does not want to wait for a better entry, this is still not an attractive purchase because the current setup lacks confirmation of a durable turnaround.
GOOS is in a weak-to-neutral technical position. MACD histogram is below zero and negatively expanding, which signals downside momentum. RSI_6 at 42.7 is neutral but leaning soft, and moving averages are converging, showing no strong trend breakout. Price is below the pivot level of 11.743, with near-term support at 11.258 and resistance at 12.228. This means the stock is sitting in a narrow range with no clear bullish breakout. The short-term pattern data suggests some upside probability, but it is not strong enough to override the broader weak setup.
["Q3 revenue grew 14.25% YoY to 694.5M, showing demand improvement.", "Global DTC comps and broad-based regional momentum were noted by analysts.", "The stock may benefit if margin execution improves in future quarters."]
["No news in the recent week, so there is no fresh catalyst driving the stock.", "Several analysts cut price targets and/or downgraded the stock after the latest quarter.", "Profitability remains challenged, with EBIT pressure from one-time bad debt charges and elevated SG&A.", "Hedge funds are selling aggressively, while insiders are neutral.", "No recent congress trading data or influential figure transactions were reported.", "No AI Stock Picker or SwingMax buy signal is present today."]
Latest reported quarter: 2026/Q3. Revenue increased 14.25% YoY to 694.5M, which is a solid top-line gain. However, net income fell 3.51% YoY to 134.8M, EPS declined 4.23% YoY to 1.36, and gross margin slipped slightly to 73.98%. That combination shows growth at the top line, but weaker bottom-line conversion and limited margin progress.
Analyst sentiment has turned negative. Goldman Sachs kept a Sell rating and cut its target to $34 from $46, citing better revenue but weaker EBIT and uncertain margin expansion. Evercore ISI cut its target to $11 and stayed In Line due to cost issues and poor visibility. Barclays downgraded to Underweight with a $10 target, saying profitability remains challenged. Baird downgraded to Neutral after a disappointing margin miss in the key fiscal Q3 season. UBS kept Neutral with a $12 target and said there are no clear near-term catalysts, with meaningful sentiment improvement not expected soon. Overall, Wall Street is leaning cautious to bearish, with more cons than pros.
